Sbi Securities Co., Ltd. Achilles Therapeutics PLC Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 322 shares of ACHL stock, worth $444. This represents 0.0% of its overall portfolio holdings.
Number of Shares
322Holding current value
$444% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACHL
# of Institutions
22Shares Held
24.3MCall Options Held
0Put Options Held
0-
Syncona Portfolio LTD Guernsey, Channel Islands, X011.1MShares$15.3 Million23.86% of portfolio
-
Bml Capital Management, LLC Zionsville, IN4.1MShares$5.66 Million2.46% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.39MShares$3.3 Million0.42% of portfolio
-
Redmile Group, LLC San Francisco, CA1.61MShares$2.22 Million0.11% of portfolio
-
Vestal Point Capital, LP New York, NY1.5MShares$2.07 Million0.12% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $56.3M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...